Loading...
Loading...
Morgan Stanley increases its price target to $29 on Overweight-rated GNC Holdings
GNC on continuing strength in sales.
Morgan Stanley says, "We are raising our 2012e EPS and price target, as GNC's sales continue to impress, due to a robust new product cycle, and strong underlying vitamin/supplement industry demand. Line extensions should continue to drive comps in 2012, and the Lucky Vitamin acquisition opens a new internet sales opportunity."
GNC closed at $34.68 a share on Tuesday.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in